Allspring Global Investments Holdings, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 204 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,120,563
-73.8%
18,701
-68.5%
0.00%
-71.4%
Q2 2023$4,284,686
+647.9%
59,427
+663.1%
0.01%
+600.0%
Q1 2023$572,885
-70.4%
7,788
-73.1%
0.00%
-66.7%
Q4 2022$1,935,997
+745.4%
28,982
+987.1%
0.00%
Q3 2022$229,000
+32.4%
2,666
+37.3%
0.00%
Q2 2022$173,000
-87.9%
1,942
-84.8%
0.00%
-100.0%
Q1 2022$1,433,000
-49.3%
12,743
-30.4%
0.00%
-33.3%
Q4 2021$2,826,00018,2980.00%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
KNOTT DAVID M 353,041$36,819,00014.92%
CARDINAL CAPITAL MANAGEMENT LLC /CT 919,994$95,946,0002.93%
Elk Creek Partners, LLC 236,862$24,702,0002.84%
Conestoga Capital Advisors, LLC 619,653$64,624,0001.56%
WOODSTOCK CORP 71,489$7,456,0001.21%
Summit Creek Advisors LLC 70,962$7,401,0001.16%
FALCON POINT CAPITAL, LLC 8,115$846,0001.08%
RICE HALL JAMES & ASSOCIATES, LLC 302,503$31,548,0001.07%
Stephens Investment Management Group LLC 508,100$52,990,0001.00%
Tygh Capital Management, Inc. 55,672$5,806,0000.96%
View complete list of LIGAND PHARMACEUTICALS INC shareholders